Data driven insights for disease and drug research

Get started Free for Academics!
Learn more
Enabling world leading pharma, biotech and academic institutions
Janssen and Janssen Pharmaceutical Companies
Leiden Academic Centre for Drug Research
Astra Zeneca
Boehringer Ingelheim
Tufts University

Transforming disease and drug research

We enable the transformation to data driven disease and drug research. From academic fundamental research, preclinical target & biomarker discovery and indication expansion to clinical analysis of toxicity, efficacy and drug response. To get therapies to patients quicker, lowering the risk and cost of drug development through data driven disease insights.
Disease Modelling

AI driven computational disease models

Our AI driven computational disease models provide unique insights into which molecular perturbations cause cell type and tissue level dysfunction and predict their effect on phenotypes and diseases and, ultimately, drug efficacy and safety.
Knowledge Base

The world's largest AI-integrated knowledge base

We use AI to recognise and connect relevant information for molecular disease and drug research. Information from hundreds of life sciences databases and millions of publications and patents is harmonised and integrated using machine reading.

The leading AI platform for collaborative disease and drug research

We enable (pre)clinical researchers to take a translational systems biology approach to disease and drug research. Powered by the largest AI integrated knowledge base researchers get access to a suite of applications including Search optimised for disease and drug biology, Analytics for multi-omics & systems biological insights and a Knowledge Graph for exploring biomolecular interaction networks.

- Target Assessment

- Gene-Disease Analysis

- Target Discovery in Oncology

- Target Discovery for Bispecific Antibodies.

- Gene Set Enrichment

- Gene Set Ranking

- Transcription Pathway Analysis.

Search - Optimised for disease and drug biology
Analytics - Systems biological multi-omics insights
Knowledge Graph - Biomolecular interaction analysis
Workflows - Target discovery & assessment (and more)
Enabling world leading pharma, biotech and academic institutions
Logo Johnson & Johnson-1
Logo Grunenthal-2
Logo Daiichi Sankyo-1
PivotSC-logo-RGB-01-1 (1)-1
Logo Sanofi
Logo EMC
Euretos Indication Expansion-2
Customer review

Indication Expansion/Drug Repurposing

"“In this project we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.” "

Global Head Large European Pharma
Euretos Target discovery-2
Customer review

Target Discovery

"“We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI Platform is a mandatory input to our target evaluation meetings”"

Associate Director Target Discovery Large European Biotech
Euretos Safety & Toxicity Analysis
Customer review

Toxicity Analysis

"“The proposed mechanism of action was very attractive. The Euretos team helped to explain the phenomenon as it was observed in mouse studies. We are very grateful for this report which has provided us with a lot of very useful information.”"

Principal Scientist Large Japanese Pharma
Euretos Patient Stratification and drug response analysis-1
Customer review

Drug Response/Efficacy

"“it really does show the value of having an independent set of eyes interpreting the data that we all have been staring at for years.”"

Principal Scientist Large US Pharma

Transforming Disease and Drug Research

Get started Free access for academic users!
Book a demo